CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
CYD
China Yuchai International Limited
There isn't enough reported data to score CYD yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CYD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
CYD's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over CYD in the historical PE scenario, which offers more potential upside but is not a forecast.
CYD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $8.12 | -62% |
| Fair | 9.7x | $11.88 | -44% |
| Current | 17x | $21.15 | — |
| Expensive | 23x | $28.76 | +36% |
Historical ranges are pointers, not guarantees.
CYD's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CYD Forward outlook
There aren't enough analyst estimates for CYD to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over CYD in the latest year-over-year earnings comparison.
CYD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $1.23 | +17% |
| Q4 2023 | $1.05 | +31% |
| Q4 2022 | $0.80 | -20% |
| Q4 2021 | $1.00 | -50% |
| Q4 2020 | $2.02 | -9% |
| Q4 2019 | $2.22 | -13% |
| Q4 2018 | $2.55 | -27% |
| Q4 2017 | $3.51 | +82% |
CYD's earnings per share have fallen from their peak: $1.23 over the past year, against $3.51 in late 2017.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over CYD in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
CYD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $2.9B | +6% |
| Q4 2023 | $2.7B | +13% |
| Q4 2022 | $2.4B | -25% |
| Q4 2021 | $3.2B | +3.3% |
| Q4 2020 | $3.1B | +14% |
| Q4 2019 | $2.7B | +11% |
| Q4 2018 | $2.4B | +0.3% |
| Q4 2017 | $2.4B | +334% |
CYD's revenue is growing: $2.9B last quarter, down 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 3.1% | -2.6 points |
| Q4 2023 | 3.4% | -3 points |
| Q4 2022 | 3.2% | -4.6 points |
| Q4 2021 | 3.1% | -7.5 points |
| Q4 2020 | 5.7% | -4.4 points |
| Q4 2019 | 6.4% | +0.8 points |
| Q4 2018 | 7.9% | +1.3 points |
| Q4 2017 | 11% | +5.1 points |
CYD's operating margin was 3.1% last quarter, down 2.6 points from the same quarter a year ago, near the bottom of its range since 2015.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
CYD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $62.9M | -58% |
| Q4 2023 | $148.3M | +$230.9M |
| Q4 2022 | -$82.6M | -$72.5M |
| Q4 2021 | -$10.1M | -108% |
| Q4 2020 | $124.7M | -0.4% |
| Q4 2019 | $125.1M | +217% |
| Q4 2018 | $39.4M | -76% |
| Q4 2017 | $162.2M | +$162.2M |
CYD still generates free cash flow, though less than at its 2017 peak: $118M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CYD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.8% | -1.5M shares |
| 1 year | -3.8% | -1.5M shares |
| 3 years | 0% | -10.2K shares |
CYD has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $42.9M |
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
| Q4 2015 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
CYD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -2.6x | Net Cash |
| Q4 2023 | -2.4x | Net Cash |
| Q4 2022 | -1.8x | Net Cash |
| Q4 2021 | -2.1x | Net Cash |
| Q4 2020 | -2.2x | Net Cash |
| Q4 2019 | -0.9x | Net Cash |
| Q4 2018 | -2.1x | Net Cash |
| Q4 2017 | -1.7x | Net Cash |
CYD has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CYD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.2 | Oversold |
| Stochastic | 2.4 | Oversold |
CYD's weekly RSI is 25 (oversold) and its Stochastic is 2 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CYD PE vs Industrials Sector
| Metric | CYD | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 29% below |
| PE % | 78 | 58 | 20 pts above |
CYD has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over CYD on trend strength, trading above more of its moving averages.
CYD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 19% below |
| 20 week MA | $35.6 | 41% below |
| 50 week MA | $41.1 | 49% below |
| 100 week MA | $32.2 | 34% below |
| 200 week MA | $20.8 | 1.7% above |
CYD has fallen below most of its moving averages, though it's still 1.7% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over CYD on returns for 2026, with the stronger performance.
CYD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.4 | $16.5 | +23% |
| 2021 | $16.5 | $11.0 | -33% |
| 2022 | $11.0 | $7.10 | -36% |
| 2023 | $7.10 | $8.38 | +18% |
| 2024 | $8.38 | $11.1 | +32% |
| 2025 | $11.1 | $35.9 | +224% |
| 2026 YTD | $35.9 | $21.2 | -41% |
CYD is down 41% so far in 2026, after finishing higher in four of the previous six years.